Enoxaparin Sodium
- Product NDC
- 63323-533
- 11-digit product format
- 633230533
- Labeler code
- 63323
- Product ID
- 63323-533_53e20cb1-9e79-4c45-a5a7-62c3904df818
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- enoxaparin sodium
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA020164
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-06-18
- Substance
- ENOXAPARIN SODIUM
- Active strength
- 30 mg/.3mL
- Pharmacologic classes
- Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020164-001 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 |
| N020164-002 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 |
| N020164-003 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 |
| N020164-004 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 |
| N020164-005 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 |
| N020164-006 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | |
| N020164-007 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 |
| N020164-008 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 |
| N020164-009 | LOVENOX | ENOXAPARIN SODIUM | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020164-001 | AP |
| N020164-002 | AP |
| N020164-003 | AP |
| N020164-004 | AP |
| N020164-005 | AP |
| N020164-007 | AP |
| N020164-008 | AP |
| N020164-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N020164-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-005 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-007 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-008 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-007 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-008 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-009 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-007 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-008 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-009 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-007 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-008 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-009 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-005 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-007 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-008 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020164-009 | AB | 1 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Enoxaparin Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ENOXAPARIN SODIUM | 30 mg/.3mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8NZ41MIK1O | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 21b095d1-5ade-43e9-9114-30fbfb2331c9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33a7d2c8-f5cf-4d97-8510-92190c5e0f12 | Product name | 7 | 20240606 |
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-533-01 | Enoxaparin Sodium | 1 in 1 CELLO PACK | INJECTION | 1 | 9 | |
| 63323-533-01 | Enoxaparin Sodium | 0.3 mL in 1 SYRINGE | INJECTION | 0.3 | 9 | |
| 63323-533-83 | Enoxaparin Sodium | 10 in 1 CARTON | INJECTION | 10 | 9 | |
| 63323-533-13 | Enoxaparin Sodium | 1 in 1 CELLO PACK | INJECTION | 1 | 7 | |
| 63323-533-13 | Enoxaparin Sodium | 0.3 mL in 1 SYRINGE | INJECTION | 0.3 | 7 | |
| 63323-533-93 | Enoxaparin Sodium | 10 in 1 CARTON | INJECTION | 10 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-533-01 | ML - Milliliter | 63323-533 | 00f2f41f-b1a1-4e03-9c62-df5cbb1b4f11 | 1 | 2020-02-13 |
| 63323-533-13 | ML - Milliliter | 63323-533 | 997c26b2-ab4b-4694-866c-7e3063c31b80 | 1 | 2019-12-10 |
| 63323-533-83 | ML - Milliliter | 63323-533 | 8b563838-62cc-4fa5-97dc-4d05f29061c5 | 1 | 2020-02-13 |
| 63323-533-93 | ML - Milliliter | 63323-533 | df02c956-0917-4911-8b50-3bc212ae4b0b | 1 | 2019-12-10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-533 | ENOXAPARIN SODIUM INJECTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 3 package rows | 20230105_21b095d1-5ade-43e9-9114-30fbfb2331c9.zip |
| 63323-533 | ENOXAPARIN SODIUM INJECTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20220125_066f27ec-352c-4051-ba29-248e292690db.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovenox | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | 5017a927-2a24-4f27-89f9-27c805bf7d59 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 |
| Lovenox | ENOXAPARIN SODIUM | Cardinal Health 107, LLC | 3d263380-4f44-4fd8-aa2a-e69702ab258f | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 |
| Lovenox | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | de6fb917-a94a-41ea-9d7d-937d4080ffcd | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 |
| Enoxaparin sodium | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | 20635579-c92d-4f6c-a332-1096d51002f2 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 63323-533 |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 066f27ec-352c-4051-ba29-248e292690db | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 020164 NDA020164 63323-533 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 854248 | enoxaparin sodium 100 MG in 1 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854255 | enoxaparin sodium 100 MG/ML Injectable Solution | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854245 | enoxaparin sodium 120 MG in 0.8 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854252 | enoxaparin sodium 150 MG in 1 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854228 | enoxaparin sodium 30 MG in 0.3 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854235 | enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854238 | enoxaparin sodium 60 MG in 0.6 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854241 | enoxaparin sodium 80 MG in 0.8 ML Prefilled Syringe | PSN | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854228 | 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854235 | 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854238 | 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854241 | 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854245 | 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854248 | 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854252 | 1 ML enoxaparin sodium 150 MG/ML Prefilled Syringe | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854255 | enoxaparin sodium 100 MG/ML Injectable Solution | SCD | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854228 | 0.3 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854235 | 0.4 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854238 | 0.6 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854241 | 0.8 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854245 | 0.8 ML ENX sodium 150 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854248 | 1 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854252 | 1 ML ENX sodium 150 MG/ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854252 | enoxaparin 150 MG per 1 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854248 | enoxaparin sodium 100 MG per 1 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854245 | enoxaparin sodium 120 MG per 0.8 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854228 | enoxaparin sodium 30 MG per 0.3 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854235 | enoxaparin sodium 40 MG per 0.4 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854238 | enoxaparin sodium 60 MG per 0.6 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854241 | enoxaparin sodium 80 MG per 0.8 ML Prefilled Syringe | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854255 | ENX sodium 100 MG/ML Injectable Solution | SY | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 9 |
| 854248 | enoxaparin sodium 100 MG in 1 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854255 | enoxaparin sodium 100 MG/ML Injectable Solution | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854245 | enoxaparin sodium 120 MG in 0.8 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854252 | enoxaparin sodium 150 MG in 1 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854228 | enoxaparin sodium 30 MG in 0.3 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854235 | enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854238 | enoxaparin sodium 60 MG in 0.6 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854241 | enoxaparin sodium 80 MG in 0.8 ML Prefilled Syringe | PSN | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854228 | 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854235 | 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854238 | 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854241 | 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854245 | 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854248 | 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854252 | 1 ML enoxaparin sodium 150 MG/ML Prefilled Syringe | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854255 | enoxaparin sodium 100 MG/ML Injectable Solution | SCD | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854228 | 0.3 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854235 | 0.4 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854238 | 0.6 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854241 | 0.8 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854245 | 0.8 ML ENX sodium 150 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854248 | 1 ML ENX sodium 100 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854252 | 1 ML ENX sodium 150 MG/ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854252 | enoxaparin 150 MG per 1 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854248 | enoxaparin sodium 100 MG per 1 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854245 | enoxaparin sodium 120 MG per 0.8 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854228 | enoxaparin sodium 30 MG per 0.3 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854235 | enoxaparin sodium 40 MG per 0.4 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854238 | enoxaparin sodium 60 MG per 0.6 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854241 | enoxaparin sodium 80 MG per 0.8 ML Prefilled Syringe | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
| 854255 | ENX sodium 100 MG/ML Injectable Solution | SY | 066f27ec-352c-4051-ba29-248e292690db | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63323-533-01 | 63323053301 | 1 in 1 CELLO PACK | Historical | |||||
| 63323-533-13 | 63323053313 | 1 in 1 CELLO PACK | Historical | |||||
| 63323-533-83 | 63323053383 | 10 CELLO PACK in 1 CARTON (63323-533-83) / 1 SYRINGE in 1 CELLO PACK (63323-533-01) / .3 mL in 1 SYRINGE | 10 cello pack | 2019-06-18 | 0000-00-00 | No | No | Current |
| 63323-533-93 | 63323053393 | 10 CELLO PACK in 1 CARTON (63323-533-93) / 1 SYRINGE in 1 CELLO PACK (63323-533-13) / .3 mL in 1 SYRINGE | 10 cello pack | 2019-06-18 | 0000-00-00 | No | No | Current |